Nephrology Times
Nephrology Times
Advertisement
Charlotte RobinsonADPKD | April 25, 2025
Lupin's generic tolvaptan tablets are now FDA-approved for treating autosomal dominant polycystic kidney disease (ADPKD).
Read More
Bradley Warady, MDNKF Spring Clinical Meetings 2025 | April 25, 2025
We spoke to David M. Hume Award winner Bradley Warady, MD, at the National Kidney Foundation Spring Clinical Meetings 2025.
Meghan Sise, MDNKF Spring Clinical Meetings 2025 | April 24, 2025
Joel Topf spoke to onconephrologist Meghan Sise about her carboplatin dosing research at SCM25.
James Tumlin, MDNKF Spring Clinical Meetings 2025 | April 23, 2025
Joel Topf caught up with James Tumlin at NKF SCM25 to talk about Dr. Tumlin's late-breaking abstract on sparsentan in FSGS.
Freely FilteredNephrology Times | April 22, 2025
This Freely Filtered episode discusses REGENCY, examining the efficacy and safety of obinutuzumab in active lupus nephritis.
Jeffrey Perl, MDNKF Spring Clinical Meetings 2025 | April 22, 2025
Joel Topf spoke with Lazarus Award winner Jeffrey Perl at the National Kidney Foundation Spring Clinical Meetings 2025.
Connie Rhee, MDNKF Spring Clinical Meetings 2025 | April 21, 2025
Joel Topf spoke with Connie Rhee at SCM25 about her study on cognitive function with dialysis vs conservative CKD management.
Bradley Marder, MDNKF Spring Clinical Meetings 2025 | April 18, 2025
Joel Topf spoke with Bradley Marder of Amgen about gout studies at the NKF Spring Clinical Meetings 2025.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 18, 2025
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
Jayme Locke, MD, MPHNKF Spring Clinical Meetings 2025 | April 17, 2025
Joel Topf spoke to Excellence in Transplantation Award winner Jayme Locke at the National Kidney Foundation SCM25.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 17, 2025
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.
Charlotte RobinsonKidney Transplantation | April 17, 2025
Tonix Pharmaceuticals and Makana Therapeutics will collaborate on preclinical xenotransplantation research and development.
Charlotte RobinsonNephrology Times | April 16, 2025
The FDA has granted Priority Review to pegcetacoplan to treat C3 glomerulopathy and primary IC-MPGN.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 16, 2025
Researchers at SCM25 presented interim results of the SPARTAN trial of sparsentan as a treatment for patients with IgAN.
Keightley Amen, BA, ELSNephrology Times | April 15, 2025
Dr. Daryl Crenshaw gave a detailed review of the significance of the APOL1 gene at the NephCure 2025 Patient Summit.
Keightley Amen, BA, ELSNephrology Times | April 15, 2025
At the NephCure Patient Summit, Montrez Lucas presented a session on how people with kidney disease can navigate insurance.
Keightley Amen, BA, ELSNephrology Times | April 15, 2025
Dr. Purva Sharma educated patients with kidney disease about clinical trials in a NephCure 2025 Patient Summit session.
Keightley Amen, BA, ELSNephrology Times | April 15, 2025
Social worker Janay Thompson shared mental health tips for patients with kidney disease at the NephCure 2025 Patient Summit.
Thomas Pham, MDKidney Transplantation | April 15, 2025
Dr. Thomas Pham spoke to us about kidney donation during National Donate Life Month.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 15, 2025
One-year results of the AFFINITY trial of atrasentan to treat proteinuria among patients with IgAN were presented at SCM25.
Advertisement
Advertisement
Latest News

April 25, 2025